PTEN and tongue neoplasm: Cetuximab significantly (P < 0.001, n = 6) delayed tumorigenesis in external head and neck (Fig. 3B with quantification in Fig. 3D) and oral tongue tumors (Fig. 3C) in Tgfbr1/Pten 2cKO mice as compared with the vehicle group (n = 5).